Fineline Cube

Follow:
14398 Articles
Legend Biotech Corporation
CompanyR&D

Legend Biotech Corporation to Establish Advanced R&D Center in Philadelphia for Next-Generation Cell Therapies

BeiGene
CompanyDrug

BeiGene Prices TEVIMBRA 10% Below Competitors Following FDA Approval for Esophageal Cancer Treatment

Unixell Biotechnology
CompanyDrug

Unixell Advances in Cell Therapy with CDE IND Acceptance

Duality Biotherapeutics
CompanyDrug

Duality Biotherapeutics’ BDCA2 ADC DB-2304 Phase I Trial Registered on ClinicalTrials.gov

BeiGene
CompanyDrug

BeiGene’s FGFR2b ADC BG-C137 Enters Phase I Clinical Trial for Advanced Solid Tumors

Bristol Myers Squibb
CompanyDrug

BMS Expands Opdivo Indication with FDA Approval for NSCLC Combo Therapy

InnoCare Pharma
CompanyDrug

InnoCare Pharma’s Orelabrutinib Achieves Milestone in SLE Clinical Trial Enrollment

Akeso Biopharma
CompanyDrug

Akeso Biopharma’s PD-1/VEGF Bispecific Antibody Study Completes Enrollment

Genmab
CompanyDeals

FRα ADC Rina-S by Genmab Enters Late-Stage Clinical Trial Following ProfoundBio Acquisition

Dizal Pharmaceutical
CompanyDrug

Dizal Pharmaceutical’s Surufatinib Earns CDE Consideration for Breakthrough Therapy in EGFR exon20ins NSCLC

Hengrui Medicine
CompanyDrug

Hengrui Pharmaceuticals’ HR19042 Capsules Designated as Breakthrough Therapy for Autoimmune Hepatitis by China NMPA

AbbVie
CompanyDrug

NMPA Clears AbbVie’s ABBV-706 for Clinical Trials Targeting SCLC and Neuroendocrine Tumors